Normative and non-market perspectives on corporate diplomacy: A case study of Novartis
Catherine E. A. McDonald
Chapter 7 in Advancing Corporate Diplomacy Research, 2026, pp 132-157 from Edward Elgar Publishing
Abstract:
Multinational enterprises engage in a wide range of non-market strategies, including the practice of corporate diplomacy. Yet despite significant scholarship on the concept's instrumental foundations, there remains scope to explore the normative dimensions of corporate diplomacy – including at the intersection of business and human rights (BHR) and political corporate social responsibility (PCSR) – given the increasing prevalence of grand challenges in the international arena. This chapter, therefore, responds to calls for empirical exploration as well as research on the concept's normative philosophical dimensions, by exploring the corporate diplomacy practices of Novartis, a Swiss MNE, in relation to access to medicine. Through a qualitative approach, this chapter analyses how corporate diplomacy practices may be influenced by normative considerations, in relation to BHR and PCSR, by a variety of stakeholders at the outcome and input levels.
Keywords: Corporate diplomacy; Grand challenges; Non-market strategy; Business and Human rights; Political corporate social responsibility; Access to medicine (search for similar items in EconPapers)
Date: 2026
ISBN: 9781035302185
References: Add references at CitEc
Citations:
Downloads: (external link)
https://www.elgaronline.com/doi/10.4337/9781035302192.00013 (application/pdf)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:elg:eechap:21994_7
Ordering information: This item can be ordered from
http://www.e-elgar.com
Access Statistics for this chapter
More chapters in Chapters from Edward Elgar Publishing
Bibliographic data for series maintained by Jack Sweeney ().